Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified.
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
24 08 2021
24 08 2021
Historique:
received:
13
02
2021
accepted:
21
04
2021
entrez:
24
8
2021
pubmed:
25
8
2021
medline:
14
9
2021
Statut:
ppublish
Résumé
In this retrospective study, we report 70 cases of Epstein-Barr virus (EBV)+ diffuse large B-cell lymphoma not otherwise specified (DLBCL-NOS) among 1696 DLBCL-NOS cases diagnosed between 2006 and 2019 (prevalence of 4.1%). At diagnosis, median age was 68.5 years; 79% of the cases presented with an advanced-stage disease (III-IV), 48% with extranodal lesions, and 14% with an hemophagocytic lymphohistiocytosis (HLH) (8 at diagnosis and 1 on therapy). A total of 46 cases presented a polymorphic pattern, and 21 were monomorphic. All had a non-germinal center B phenotype, with the majority of tumor cells expressing CD30 and programmed death ligand 1 (98% and 95%, respectively). Type II and III EBV latency was seen in 88% and 12% of the cases, respectively. Patients were treated with immunochemotherapy (59%) or chemotherapy (22%), and 19% received palliative care due to advanced age and altered performance status. After a median follow-up of 48 months, progression-free survival (PFS) and overall survival (OS) at 5 years were 52.7% and 54.8%, respectively. Older age (>50 years) and HLH were associated with shorter PFS and OS in multivariate analysis (PFS: hazard ratio [HR], 14.01; 95% confidence interval [CI], 2.34-83.97; and HR, 5.78; 95% CI, 2.35-14.23; OS: HR, 12.41; 95% CI, 1.65-93.53; and HR, 6.09; 95% CI, 2.42-15.30, respectively). Finally, using a control cohort of 425 EBV- DLBCL-NOS, EBV positivity was associated with a shorter OS outcome within patients >50 years (5-year OS, 53% [95% CI, 38.2-74] vs 60.8% [95% CI, 55.4-69.3], P = .038), but not in younger patients.
Identifiants
pubmed: 34427583
pii: S2473-9529(21)00413-4
doi: 10.1182/bloodadvances.2021004515
pmc: PMC8405194
doi:
Substances chimiques
Ki-1 Antigen
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3227-3239Informations de copyright
© 2021 by The American Society of Hematology.
Références
Mod Pathol. 2012 Jul;25(7):968-82
pubmed: 22538516
Pediatr Blood Cancer. 2007 Feb;48(2):124-31
pubmed: 16937360
Hematol Oncol. 2017 Mar;35(1):87-93
pubmed: 26177728
Lancet. 2014 Apr 26;383(9927):1503-1516
pubmed: 24290661
Ann Oncol. 2015 Mar;26(3):548-55
pubmed: 25475080
Hematol Oncol. 2018 Feb;36(1):93-97
pubmed: 28639256
Br J Haematol. 2020 Apr;189(2):257-268
pubmed: 31958882
Br J Haematol. 1999 Mar;104(4):672-9
pubmed: 10192425
Clin Cancer Res. 2012 Mar 15;18(6):1611-8
pubmed: 22271878
Leuk Lymphoma. 2019 Jan;60(1):19-28
pubmed: 29966474
Mod Pathol. 2011 Aug;24(8):1046-54
pubmed: 21499229
Clin Microbiol Infect. 2015 Jun;21(6):596-602
pubmed: 25743579
Leuk Lymphoma. 2011 Apr;52(4):613-9
pubmed: 21299462
Blood. 2015 Aug 13;126(7):863-72
pubmed: 25999451
Br J Haematol. 2015 Jan;168(1):63-8
pubmed: 25157895
Blood. 2013 Jul 18;122(3):328-40
pubmed: 23649469
Hum Pathol. 2007 Sep;38(9):1293-304
pubmed: 17707260
Br J Haematol. 2014 Dec;167(5):608-17
pubmed: 25135752
Br J Haematol. 2018 Oct;183(1):68-75
pubmed: 30043391
Clin Cancer Res. 2007 Sep 1;13(17):5124-32
pubmed: 17785567
J Hematol Oncol. 2016 Oct 13;9(1):109
pubmed: 27737703
Am J Surg Pathol. 2003 Jan;27(1):16-26
pubmed: 12502924
Am J Surg Pathol. 2019 Mar;43(3):341-351
pubmed: 30540571
Am J Hematol. 2018 Jul;93(7):953-962
pubmed: 29984868
J Clin Oncol. 2014 Sep 20;32(27):3059-68
pubmed: 25113753
Pediatr Dev Pathol. 2018 Jan-Feb;21(1):95-99
pubmed: 29187030
Am J Hematol. 2013 Sep;88(9):774-9
pubmed: 23760676
Pathology. 2020 Jun;52(4):453-459
pubmed: 32305135
Blood. 2012 Jan 19;119(3):673-86
pubmed: 22096243
Leuk Lymphoma. 2010 Jan;51(1):66-72
pubmed: 19860616
Hum Pathol. 2009 May;40(5):653-61
pubmed: 19144386
N Engl J Med. 2003 Oct 2;349(14):1324-32
pubmed: 14523140
Eur J Cancer. 2018 Aug;99:86-96
pubmed: 29935491
Clin Lymphoma Myeloma Leuk. 2011 Dec;11(6):512-6
pubmed: 21889434
Oncologist. 2011;16(1):87-96
pubmed: 21212426
J Clin Oncol. 2012 Jun 20;30(18):2190-6
pubmed: 22614995
Eur Rev Med Pharmacol Sci. 2020 Jan;24(17):8947-8956
pubmed: 32964985
Nat Rev Cancer. 2004 Oct;4(10):757-68
pubmed: 15510157
Blood Adv. 2020 Jun 9;4(11):2523-2535
pubmed: 32516416
J Int Med Res. 2020 Feb;48(2):300060519882233
pubmed: 31642356
Haematologica. 2018 Feb;103(2):297-303
pubmed: 29170255
Oncotarget. 2014 Dec 15;5(23):11813-26
pubmed: 25544772
Case Rep Hematol. 2016;2016:2103612
pubmed: 27803821
APMIS. 2011 Apr;119(4-5):309-16
pubmed: 21492232
Adv Anat Pathol. 2011 Sep;18(5):349-55
pubmed: 21841405
Oncotarget. 2016 Sep 13;7(37):59976-59986
pubmed: 27527850
Hum Pathol. 2015 May;46(5):716-24
pubmed: 25704629
Oncotarget. 2014 Dec 15;5(23):12189-202
pubmed: 25361008
ACG Case Rep J. 2017 May 24;4:e68
pubmed: 28584842
Br J Haematol. 1997 Dec;99(3):656-64
pubmed: 9401080
Leukemia. 2019 Jul;33(7):1687-1699
pubmed: 30683910
Am J Hematol. 2011 Aug;86(8):663-7
pubmed: 21761432
Leuk Lymphoma. 2013 Feb;54(2):298-303
pubmed: 22830615
Clin Cancer Res. 2014 May 1;20(9):2338-49
pubmed: 24583797
Clin Cancer Res. 2013 Jul 1;19(13):3462-73
pubmed: 23674495
Virchows Arch. 2015 Nov;467(5):571-82
pubmed: 26369546
Blood. 2011 May 5;117(18):4726-35
pubmed: 21385849
Blood. 2019 Jun 6;133(23):2465-2477
pubmed: 30992265
Ann Diagn Pathol. 2016 Dec;25:7-14
pubmed: 27806850
J Hematol Oncol. 2019 Jun 10;12(1):58
pubmed: 31182108
Hum Pathol. 2010 Mar;41(3):352-7
pubmed: 19913281
Cancer. 2017 Sep 1;123(17):3326-3334
pubmed: 28464214
Am J Hematol. 2016 Nov;91(11):1161-1164
pubmed: 27414752
J Clin Oncol. 2015 Nov 10;33(32):3759-65
pubmed: 26261247
Blood. 2011 May 12;117(19):5019-32
pubmed: 21300984
Jpn J Clin Oncol. 2014 Dec;44(12):1164-71
pubmed: 25320341
Nat Rev Immunol. 2003 Oct;3(10):801-12
pubmed: 14523386
Blood. 2007 Aug 1;110(3):972-8
pubmed: 17400912
J Clin Oncol. 2016 Aug 10;34(23):2690-7
pubmed: 27069084
Blood. 2004 Jan 1;103(1):275-82
pubmed: 14504078
Ann Hematol. 2007 Jul;86(7):493-8
pubmed: 17347847
Histopathology. 2017 Jul;71(1):89-97
pubmed: 28231401
Sci Rep. 2015 Jul 23;5:12168
pubmed: 26202875
Br J Haematol. 2015 Aug;170(4):539-49
pubmed: 25940575
BMC Hematol. 2016 Nov 24;16:28
pubmed: 27904750